Callodine Capital Management’s Sanofi SNY Stock Holding History

Callodine Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-698,046	Closed	-$32.9M	–	61
2025 Q3	$32.9M	Buy	698,046 +182,837	+35%	+$8.82M	2.89%	11
2025 Q2	$24.9M	Buy	515,209 +109,240	+27%	+$5.58M	2.58%	15
2025 Q1	$22.5M	Buy	405,969 +21,780	+6%	+$1.18M	3.75%	10
2024 Q4	$18.5M	Buy	384,189 +20,000	+5%	+$1.02M	3.83%	8
2024 Q3	$21M	Sell	364,189 -15,000	-4%	-$810K	4.38%	8
2024 Q2	$18.4M	Buy	379,189 +10,000	+3%	+$482K	4.29%	7
2024 Q1	$17.9M	Buy	369,189 +69,189	+23%	+$3.38M	4.34%	8
2023 Q4	$14.9M	Buy	300,000 +55,000	+22%	+$2.69M	3.93%	9
2023 Q3	$13.1M	Sell	245,000 -15,000	-6%	-$800K	3.66%	10
2023 Q2	$14M	Sell	260,000 -85,000	-25%	-$4.57M	4.02%	10
2023 Q1	$18.8M	Sell	345,000 -5,000	-1%	-$243K	5.54%	6
2022 Q4	$17M	Buy	350,000 +50,000	+17%	+$2.19M	5.05%	7
2022 Q3	$11.4M	Buy	300,000 +133,065	+80%	+$5.93M	3.55%	12
2022 Q2	$8.35M	Buy	+166,935	New	+$8.86M	2.47%	20

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Callodine Capital Management's SNY Position: Q4 2025 in Review

Callodine Capital Management sold out of Sanofi (SNY) in Q4 2025, closing a stake of 698,046 shares — an estimated $32.9M sold.

Callodine Capital Management first reported a position in SNY in Q2 2022 and held it in 14 quarters. The position peaked at $32.9M in Q3 2025. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

Callodine Capital Management reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
Callodine Capital Management sold 698,046 Sanofi shares in Q4 2025, an estimated $32.9M.
Callodine Capital Management first reported a position in Sanofi in Q2 2022 and held it in 14 quarters.
Callodine Capital Management's Sanofi position peaked at $32.9M in Q3 2025.
757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Callodine Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.